This Week in Psychedelics - 1.22.21

Cannabis

• France launches public consultation on legalising cannabis (France24)

• UFC ditch marijuana ban but fighters warned to ‘temper enthusiasm’ after Usada rule change (The Independent)

• Biden Taps Marijuana Legalization Supporter To Lead Democratic National Committee (Marijuana Moment)

• American Medical Association Asks Court To Overturn Medical Marijuana Vote In Mississippi (Marijuana Moment)

• Arizona: Adult Use Marijuana Sales On Track to Begin This Month (NORML)

• This Michigan marijuana dispensary is giving free weed to anyone who got the COVID-19 vaccine (Detroit Metro Times)

• Trump Grants Clemency To Marijuana Prisoners On Last Day In Office (Marijuana Moment)

• Study: Nearly Half of Medical Cannabis Users Cease Using Opioids for Pain After Twelve Months (NORML)

• Congressman Files First Federal Marijuana Reform Bill Of 2021 (Marijuana Moment)

• Could Medical Cannabis Help with the Treatment of Movement Disorders? (Canex)

• Latest Canadian cannabis recalls include melting vape pens, moldy bud (Marijuana Business Daily)

• Virginia Marijuana Legalization Bill Approved By Senate Committee, With Home Cultivation Provisions Intact (Marijuana Moment)

• “Game changer” for the sector: First cannabis company expected to list on LSE next month (Cannabis Health News)

• Police Find 1st 'Cannabis Factory' In London's Financial District, Destroy 826 Plants (NPR)

• Hash landing: New Zealand police ditch annual helicopter hunt for cannabis dens (The Guardian)

• Phytol cited as potentially dangerous cannabis vape ingredient (Marijuana Business Daily)

• Study: Cannabis Use Associated with Reduced Alcohol Intake Among Treatment-Seeking Drinkers (NORML)

• Research establishes antibiotic potential for cannabis molecule (ScienceDaily)

• Women who use cannabis may have harder time conceiving (Healio)

• How Some THC Is Legal — For Now (Rolling Stone)

Magic Mushrooms

• Florida Lawmaker Introducing Psilocybin Mushroom Legalization (Forbes)

• Unique magic mushroom microdosing study to begin in Australia (New Atlas)

• How Mixing Mushrooms and MDMA Affects Your Body and Brain (VICE)

• Patient hopes Canada will introduce regulations for treatment with 'magic mushrooms' (CTV News)

• BC Craft Supply Co Announces Letter of Intent with Psilocybin Research and Development Company Ava Pathways (Globe Newswire)

MDMA

• MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD (Psilocybin Alpha)

Ayahuasca

• Insight into Ayahuasca’s Antidepressant Effects (Psychedelic Science Review)

5-MeO-DMT

• New Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate (Psychedelic Science Review)

Synthetic Cannabinoids

• NCSA: Synthetic cannabis a cause for concern (Loop Barbados)

Ketamine

• Ketamine Clinicians Publish Ethical Guidelines to Raise Treatment Standards (Lucid News)

• Colorado officials resume review of ketamine program after Elijah McClain's death (CNN)

• PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders (Psilocybin Alpha)

Miscellaneous

• Icelandic Government Proposes Drug Decriminalisation (The Reykjavik Grapevine)

• Peter Thiel-backed psychedelics start-up targets schizophrenia ahead of IPO (CNBC)

• Psychedelic Therapy Schools Are Popping Up Like Mushrooms (Bloomberg)

• The Biden Administration and Drug Policy: Expectation Versus Reality (Filter)

• North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF? (Psilocybin Alpha)

• A New Supreme Court RFRA Ruling May Be a Boon to Psychedelic Religions (Chacruna)

• Senator wants to 'lock in' 2020 drug laws (Idaho Press)

• NeonMind Lists on the Frankfurt Stock Exchange (Psilocybin Alpha)

• Is Psychedelic Medicine the Antidote to Anti-Black White Racism in the US? (Chacruna)

• The Therapeutic Potential of Psychedelics and Nature Explored in New Study (Lucid News)

• Psychedelic Authoritarianism Harm Reduction: “QAnon Shaman” Edition (Psymposia)

• Here’s What’s Missing From Conversations About Psychedelic Integration (DoubleBlind)

• Attorney General Merrick Garland a Disheartening Prospect (Filter)

• Dopamine Release and Duration of Action: Rules of Thumb to Predict Addictive Potential of Phenethylamines (Spirit Pharmacist)

• Ergot in Canada: A Lost Tradition? (Chacruna)

• BetterLife Pharma Is Developing Second Generation Psychedelics: Drugs That Leave Out The Trip (Forbes)

• Former Defence Force chief Chris Barrie supports increased accessibility of psychedelic drugs (The Canberra Times)

• Could Biden Make His Country’s Global Drug War Even More Imperialist? (Filter)

• What Will The Psychedelics Space Look Like In 2021? Experts Weigh In (Yahoo! Finance)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.15.21

Cannabis

• South Dakota: Republican Governor Officially Backing Litigation to Reject Voter-Approved Marijuana Legalization Initiative (NORML)

• Montana Lawmakers Reject Funding To Implement Voter-Approved Marijuana Legalization Program (Marijuana Moment)

• Mississippi: Medical Organizations Join Legal Fight to Overturn Election Result Legalizing Medical Cannabis Access (NORML)

• Amsterdam doubles down on plans to restrict tourist access to cannabis coffee shops (CNN)

• New Jersey Is ‘On The Verge’ Of Implementing Marijuana Legalization, Governor Says In State Of The State Speech (Marijuana Moment)

• Mexico releases long-awaited medical cannabis regulations (Marijuana Business Daily)

• Activists Give Out Free Marijuana To Encourage COVID Vaccination With ‘Joints For Jabs’ Campaign (Marijuana Moment)

• USDA Releases Final Rule For Hemp, Two Years After Crop Was Federally Legalized (Marijuana Moment)

• UK grants second only licence to grow medical marijuana (Financial Times)

• Virginia Governor Unveils Bill To Legalize Marijuana As Lawmakers Schedule First Hearing (Marijuana Moment)

• New Mexico Governor Says Marijuana Legalization Is A 2021 Priority (Marijuana Moment)

• Kansas Lawmakers Push To Legalize Medical Marijuana In 2021 (Marijuana Moment)

• Colorado authorities issue recall of contaminated cannabis (Marijuana Business Daily)

• USDA Approves Hemp Regulatory Plans From Rhode Island And Another Indian Tribe (Marijuana Moment)

• The Future of Fully Legal Cannabis (Playboy)

• Top Texas Lawmakers Say Medical Marijuana Expansion Is On The Table For 2021 (Marijuana Moment)

• Survey: Most Americans Say Marijuana Possesses Less Abuse Potential Than Alcohol (NORML)

• North Dakota Activists Submit 2022 Marijuana Legalization Ballot Initiative (Marijuana Moment)

• North Dakota Lawmakers File Bill To Significantly Expand Marijuana Decriminalization Law (Marijuana Moment)

• Legalizing marijuana boosts junk food sales (The Academic Times)

• Medical Marijuana Leads To Reduced Opioid Use, New Study Finds (Marijuana Moment)

• Cannabis dispensaries struggle to find financial support amid pandemic (KRON4)

• FDA Unveils Plan To Fill CBD Research Gaps With ‘Real-World Data’ In 2021 (Marijuana Moment)

• Introducing Mode: The world's first smart cannabis dosing device (KVVU-TV)

• Arizona Prepares To Accept Marijuana Applications Next Week As New Draft Legalization Rules Are Issued (Marijuana Moment)

LSD

• LSD Could Be the Key to Alleviating the Mental Health Crisis—if Government Allows It (Foundation for Economic Education)

• MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers (Psilocybin Alpha)

Magic Mushrooms

• Psychedelic Mushrooms Grew in a Man's Veins After He Injected Them (Gizmodo)

• NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity (Psilocybin Alpha)

• Psilocybin is Being Studied to Help Treat Autism Spectrum Disorder (Baystreet)

• Psilocybin produces an immunology-related genetic response in the prefrontal cortex of pig brains (PsyPost)

• CBDV Begins Research on Psilocybin with Section 56 Exemption from Health Canada (Psilocybin Alpha)

• Core One Labs Announces Breakthrough in Solving Psilocybin Dosing Problems by Introducing Biosynthetic Psilocybin to its Patented Thinstrip Delivery Method (AccessWire)

• Silo Pharma Provides Details of Patent License Agreement for Psilocybin and Cancer Applications (GlobeNewswire)

• Revive Therapeutics Announces Research Collaboration with North Carolina State University for Natural Biosynthesis Enzymatic Platform To Develop Psilocybin (Psilocybin Alpha)

MDMA

• Should You Say “I Love You” While on MDMA? (DoubleBlind)

• Awakn Life Sciences Appoints CRO to Conduct Phase II Study of MDMA as a Treatment for Alcohol Use Disorder (Psilocybin Alpha)

Peyote

• Inside a Massive, Illicit Peyote Ceremony During Mexico's COVID Lockdown (VICE)

Iboga

• Ibogaine vs. Iboga Alkaloids for Treating Addiction (Psychedelic Science Review)

Nitrous Oxide

• Police investigation launched after cargo of nitrous oxide canisters discovered in Ribble Valley (Burnley Express)

Ketamine

• A Deadly ‘Ketamine Cocktail’ Is Causing Overdoses on the Streets of Bangkok (VICE)

• Novamind Expands Psychedelic Medicine Access in Utah (Psilocybin Alpha)

Miscellaneous

• Somerville, Massachusetts Decriminalizes Naturally Occurring Psychedelics (DoubleBlind)

• COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care (COMPASS Pathways)

• New York, Virginia And Other States Consider New Drug Decriminalization Bills (Marijuana Moment)

• The World's ‘Largest Illegal Darknet Marketplace’ has Been Shut Down (VICE)

• UFC looks into Johns Hopkins study on psychedelic drugs as potential therapy for fighters (ESPN)

• Michigan Prosecutor Won’t Pursue Most Marijuana Or Psychedelics Cases, ‘Regardless Of The Amount’ (Marijuana Moment)

• DEA Agents Report Agency’s Lack of Basic COVID-19 Safety Measures (Filter)

• When Getting High Is a Hobby, Not a Habit (New York Times)

• How This Black-Led Psychedelic Collective Is Combining Anti-Racism With ‘Sacred Plant Medicine’ (Vogue)

• Eleusis Accelerates Psychedelic Drug Discovery and Development Team with Appointment of David Nichols, Ph.D., as Director of Molecular Pharmacology (Psilocybin Alpha)

• Coping with Antidepressants and Psychedelics (Spirit Pharmacist)

• Psychedelic Illusions are Not Pathological, and May Even Help You See Better (Chacruna)

• Engineering Psychoplastogens: Toward a Safer Alternative for Treating Depression (Psychedelic Science Review)

• Silo Pharma Enters into Sponsored Research Agreement for Potential Multiple Sclerosis Treatment Approach with University of Maryland, Baltimore (Psilocybin Alpha)

• Revealing Trends in Russia’s Dark-Web Drug Markets (TalkingDrugs)

• Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectometer (Cision)

• Having A Bad Trip On Psychedelics: Is There Some Value? (Healing Maps)

• The Emerging Revival of Psychedelics in Neuroscience (Psychology Today)

• Mental Health Demand For Development Of Psychedelic Drug Therapies Is Increasing (PR Newswire)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.8.21

Cannabis

• What The New Democratic-Controlled Senate Means For Federal Marijuana Legalization In 2021 (Marijuana Moment)

• These States Are The Most Likely To Legalize Marijuana In 2021 (Marijuana Moment)

• Incarcerated Patients Have A Right To Use Medical Marijuana, New Mexico Judge Rules (Marijuana Moment)

• Illinois: Governor Vacates Half a Million Past Marijuana Convictions (NORML)

• Virginia Lawmaker Introduces Bill To Legalize Marijuana In 2021 (Marijuana Moment)

• New Bill On Underage Marijuana Possession Could End New Jersey Legalization Stalemate Between Governor and Lawmakers (Marijuana Moment)

• Study: Marijuana Use Not Associated with Increased Risk of Cardiovascular Disease (NORML)

• Scientists Cite Obscure Federal Marijuana Memo In Scheduling Case Against DEA (Marijuana Moment)

• Mother fears son could die as Brexit stops medical cannabis supply (The Guardian)

• Biden AG Pick Merrick Garland Wants To Defer To DEA On Marijuana Science And Classification (Marijuana Moment)

• California: No Uptick in Frequency of Marijuana Use by Young Adults Following Adult-Use Legalization (NORML)

• New York Governor Unveils Updated Marijuana Legalization Plan For 2021 (Marijuana Moment)

LSD

• Here’s What Happens When Animals Eat LSD (DoubleBlind)

Magic Mushrooms

• This Former Latter-day Saint Politician Started a Psilocybin Church—But Is it Legal? (DoubleBlind)

• The Effects of Psilocybin on Morality and Empathy (Psychedelic Science Review)

• Alberta Palliative Patient Successfully Undergoes First Legal Psychedelic-Assisted Therapy in Alberta, Initial Outcomes Exceed Expectations (Psilocybin Alpha)

• Will psychedelic mushroom vacations come to the US? (The Washington Post)

• MycoMeditations' Psilocybin-Assisted Wellness Retreat Announces New Leadership and Its Early 2021 Program Calendar (PR Newswire)

• NeonMind Goes Public, Plans To Study Functional Mushrooms And Psilocybin As Treatments (Benzinga)

MDMA

• Field Trip Health Ltd. Announces Participation in a MAPS-sponsored Multi-Site Study of MDMA-Assisted Therapy to Treat Eating Disorders (Psilocybin Alpha)

DMT

• New Clinical Trial Explores Safety of DMT for Substance Use Disorders (Technology Networks)

5-MeO-DMT

• Hamilton Morris Synthesizes 5-MeO-DMT in “Pharmacopeia” (Psychedelic Science Review)

• A Look at: 5MEO: Are Some Doors Better Left Unopened? (Reality Sandwich)

Ketamine

• Repeated Ketamine Infusions Reduce Symptom Severity in Individuals With Chronic Post-Traumatic Stress Disorder (Newswise)

• Ethical Concerns About Marketing Ketamine as a Safe and Effective Antidepressant (Medium)

Miscellaneous

• Jake Angeli: The Psychedelic Guru Who Stormed The Capitol (Psymposia)

• Big pharma is about to tune in to the potential of psychedelics (WIRED)

• Clandestine chemistry and psychoactive drugs in film: Hamilton Morris talks about his career (Chemical and Engineering News)

• Best Music Playlists For Psychedelic Therapy Are Explored In New Johns Hopkins Study (Marijuana Moment)

• Mount Sinai Health System Launches Center for Psychedelic Research (Psilocybin Alpha)

• Tooth tartar could uncover the drug habits of ancient people (Science)

• Are the Subjective Effects of Psychedelics Necessary for Their Therapeutic Benefits? (Psychedelic Science Review)

• Oakland’s Next Step in Psychedelic Decriminalization Approved Unanimously by City Council (Lucid News)

• Neuroscientists believe deep neural networks could help illustrate how psychedelics alter consciousness (PsyPost)

• What Is Raphael Warnock’s Record on Drug Policy and Harm Reduction? (Filter)

• What do Alien Abduction and Psychedelic Experiences have in Common? Let Dr. John E. Mack’s Work Explain (Psychedelics Today)

• Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia (Psilocybin Alpha)

• God's Factory Reset (Reset.me)

• NeonMind Appoints Trevor Millar as Chief Psychedelic Officer (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.20.20

Cannabis

• Mexican Senate Passes Bill To Legalize Marijuana Nationwide (Marijuana Moment)

• Israel Announced Intentions To Legalize Recreational Cannabis (High Times)

• Argentina redraws medical cannabis rules, allowing home cultivation (Marijuana Business Daily)

• Cannabis resin now 25% more potent, global study reveals (The Guardian)

• New Jersey Senate Approves Marijuana Decriminalization Despite Contentious Psychedelics Provision (Marijuana Moment)

• CBD is not a narcotic, says EU court as it rules French ban is illegal (The Guardian)

• Lawmakers In Wisconsin Capital Vote To Allow Marijuana Use In Public (Marijuana Moment)

• How marijuana legalization made strides across the US in this election (The Guardian)

• New Jersey Senate And Assembly Committee Pass Marijuana Sales Bills Despite Pushback From Equity Advocates (Marijuana Moment)

• New Jersey: Senate Lawmakers Approve Legislation to End Low-Level Marijuana Arrests (NORML)

LSD

• Joanna Harcourt-Smith, Lover of Timothy Leary, High Priest of LSD, Dies at 74 (The New York Times)

• MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities (Psilocybin Alpha)

• Florida man on LSD tackles Disney security guard at Animal Kingdom (Orlando Weekly)

Magic Mushrooms

• First Non-Palliative Canadian Granted Access To Psilocybin Therapy (Psilocybin Alpha)

• Usona Offers Psilocybin to Eligible Researchers at No Cost (Usona Institute)

• Revive Therapeutics Announces Research Collaboration with PharmaTher for Development of Psilocybin in Cancer and Discovery of Novel Uses of Psychedelics (Psilocybin Alpha)

• Psilocybin increases the expression neuroplasticity-related genes in rats (PsyPost)

• Psilocybin for Depression Study Approved and Funded by German Government (Psilocybin Alpha)

• Pilot Study of Psilocybin-Assisted Group Therapy in Older AIDS Survivors (Psychedelic Science Review)

• Single Dose of Psilocybin Reduces Migraines for at Least 2 Weeks (Psilocybin Alpha)

• Aeruginascin Identified in Psilocybe cubensis Magic Mushrooms (Psychedelic Science Review)

• NeonMind Commences Preclinical Trial to Examine Psilocybin for Weight Loss (Psilocybin Alpha)

• How will Oregon’s new psilocybin therapy program work? (OPB)

• Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders (Psilocybin Alpha)

• ACT and PcbAP for Depression – A Natural Synergy Part 2: The Technical Integration (Psychedelic Science Review)

• Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program (Psilocybin Alpha)

Ketamine

• Happiness during ketamine infusion predicts treatment-resistant depression outcomes (Healio)

• Ketamine May Be Helpful in Treating Alcohol Use Disorder (Psychology Today)

• Veterans Are Using Ketamine-Assisted Psychotherapy To Help With PTSD (Green Entrepreneur)

Miscellaneous

• Vancouver proposes decriminalizing possession of small amounts of drugs (The Globe and Mail)

• Canadian Officials Respond To Psychedelics Decriminalization Petition, Saying No Legal Changes Needed (Marijuana Moment)

• UK on the Brink of a Psychedelic Therapy Revolution (Filter)

• One Simple Way Biden Could Prove He Regrets His Role in the Drug War (Slate)

• How Tripping Can Help Us Reimagine Capitalism Ahead of Psychedelic Commercialization (DoubleBlind)

• High Country: The Aspen Brain Institute examines the promising future of psychedelic-assisted therapy (The Aspen Times)

• The Oregon Model (The Baffler)

• Keys for Integrating Psychedelic Experiences (Psychedelics Today)

• Kin Spruijt: A Psychedelic Nurse in a Dutch Psychiatric Clinic (Chacruna)

• Paraphernalia Decrim Advances in DC—Just Not for Drug Sellers (Filter)

• Breaking Barriers So Psychedelic Experiences Can Become Mainstream (Forbes)

• What is the Default Mode Network? (Psychedelic Science Review)

• Avoiding Negative Experiences With Microdosing (The Third Wave)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.13.20

Cannabis

• House will vote on cannabis legalization bill in December (Politico)

• Mexican Senators Will Vote On Revised Marijuana Legalization Bill This Week (Marijuana Moment)

• Can Marijuana Help Biden Heal a Divided Nation? (Bloomberg)

• Marijuana Reform Omitted From Biden Transition Plan On Racial Equity Despite Campaign Pledges (Marijuana Moment)

• Gallup: Record Percentage of Americans Say “Marijuana Should Be Made Legal” (NORML)

• New Jersey Committees Cancel Marijuana Sales Bill Votes Amid Disputes Over Provisions (Marijuana Moment)

• Virginia: Legislation Barring Police from Using Marijuana Odor to Stop or Search Takes Effect Early 2021 (NORML)

• Texas Lawmakers Pre-File Marijuana Bills For 2021 Session (Marijuana Moment)

• People around the country keep voting for marijuana. Here's why that's unlikely in NC. (The News & Observer)

• Montana Marijuana Opponents File New Lawsuit To Overturn Legalization Vote (Marijuana Moment)

• Cannabis May Have Negative Effects On Sperm, Review Finds (Benzinga)

• Marijuana Regulators From 19 States Form Group To Coordinate Legalization Implementation (Marijuana Moment)

• After heart attack, pot smoking raises post-op dangers (Medical Xpress)

LSD

• Free Love and LSD: Photos of Life in a 70s Commune (VICE)

Magic Mushrooms

• Bill to decriminalize marijuana in N.J. passes in committee — and is amended to include hallucinogenic mushrooms (The Philadelphia Inquirer)

• Revive Therapeutics Provides Update on Oral Thin Film Product with Psilocybin (Psilocybin Alpha)

• Niños Santos, Psilocybin Mushrooms and the Psychedelic Renaissance (Chacruna)

• NeonMind Obtains Health Canada Approval to Advance Psilocybin Research (Psilocybin Alpha)

MDMA

• MDMA does not increase trust or cause a hangover, study says (New York Post)

DMT

• Meet the Man Who Brought DMT to the Masses (VICE)

Ayahuasca

• The Ayahuasca Afterglow Phenomenon: Exploring Its Significance and Limitations (Psychedelic Science Review)

• Jordi Riba and the Challenges of Studying Ayahuasca (Psychedelic Science Review)

Ketamine

• New Program Brings Ketamine-Assisted Psychotherapy to Canadian Vets (Lucid News)

• Silo Wellness Announces the First-of-Its-Kind U.S.-Legal Psychedelic Wellness Nature Retreat in Oregon (Psilocybin Alpha)

• Microscopes, Telescopes, and Ketamine (The Third Wave)

Miscellaneous

• California Could Decriminalize Psychedelics Under New State And Local Proposals (Marijuana Moment)

• What happens when psychedelics make you see God (Popular Science)

• Psychedelics Won the Election—Except the Psychedelic that is Donald Trump (DoubleBlind)

• Can Microdosing Make You a Better Athlete? (Playboy)

• DEA Pursues Vast Expansion of Patient Surveillance (Filter)

• The Cost of Exclusion in Psychedelic Research (Bill of Health)

• Here’s why Black people in the UK are turning to psychedelics (gal-dem)

• Psychedelic Scientists Should Honor Indigenous Plants and Traditions (Chacruna)

• Europe's Teenage Drug Use Hotspots Revealed By New Study (VICE)

• A Handful of Start-Ups Is Developing Psychedelic Drugs for Mental Illnesses. It Could Be a Bad Trip for Investors. (Barron's)

• Banned Lecture of Getting Higher (Psychedelic Press UK)

• The Cost of Omission: Dr. Valentina Wasson and Getting Our Stories Right (Chacruna)

• Cybin Goes Public on the NEO Exchange Under Symbol CYBN (Psilocybin Alpha)

• Silo Pharma, Inc. Launches Scientific Advisory Board with Appointment of Dr. Matthew Johnson of John Hopkins University (Psilocybin Alpha)

• Can Psychedelics Treat Eating Disorders? (DoubleBlind)

• Growing Up with Sacred Plants (Chacruna)

• Entheon Biomedical Corp. Commences Trading on the Canadian Securities Exchange (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.